Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Guy

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
The Journal of Biological Chemistry|February 12, 1998
MAGI-1, a membrane-associated guanylate kinase with a unique arrangement of protein-protein interaction domainsI Dobrosotskaya, R K Guy, G L James
Trends in Biotechnology|January 22, 2013
Biobased plastics in a bioeconomyJ C Philp, R J Ritchie, K Guy
Clinical and Experimental Immunology|February 1, 1986
Deficient expression of MHC class II antigens in some cases of human B cell leukaemiaK Guy, L J Docherty, A E Dewar
Scientific American|June 1, 1996
Taxoids: new weapons against cancerK C Nicolaou, R K Guy, P Potier
Journal of Immunological Methods|September 13, 1988
Indirect immunofluorescence labelling with complexes of phycoerythrin and monoclonal anti-phycoerythrin antibodies (PEAPE complexes)K Guy, D N Crichton, J A Ross
Immunology|September 19, 1998
Prostaglandin and fatty acid modulation of Escherichia coli O157 phagocytosis by human monocytic cellsJ Davidson, A Kerr, K Guy, et al.
Transplantation|August 1, 1974
Passive enhancement of mouse skin allografts. Specificity of the antiserum for major histocompatibilityN A Staines, K Guy, D A Davies
Organic Letters|July 13, 2000
Copper-mediated cross-coupling of aryl boronic acids and alkyl thiolsP S Herradura, K A Pendola, R K Guy
Immunogenetics|January 1, 1982
Human MHC class II molecules as differentiation markersV van Heyningen, K Guy, R Newman, et al.
European Journal of Immunology|February 1, 1983
Enhanced expression of human Ia antigens by chronic lymphocytic leukemia cells following treatment with 12-O-tetradecanoylphorbol-13-acetateK Guy, V Van Heyningen, E Dewar, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
The Journal of Biological Chemistry|February 12, 1998
MAGI-1, a membrane-associated guanylate kinase with a unique arrangement of protein-protein interaction domainsI Dobrosotskaya, R K Guy, G L James
Trends in Biotechnology|January 22, 2013
Biobased plastics in a bioeconomyJ C Philp, R J Ritchie, K Guy
Clinical and Experimental Immunology|February 1, 1986
Deficient expression of MHC class II antigens in some cases of human B cell leukaemiaK Guy, L J Docherty, A E Dewar
Scientific American|June 1, 1996
Taxoids: new weapons against cancerK C Nicolaou, R K Guy, P Potier
Journal of Immunological Methods|September 13, 1988
Indirect immunofluorescence labelling with complexes of phycoerythrin and monoclonal anti-phycoerythrin antibodies (PEAPE complexes)K Guy, D N Crichton, J A Ross
Immunology|September 19, 1998
Prostaglandin and fatty acid modulation of Escherichia coli O157 phagocytosis by human monocytic cellsJ Davidson, A Kerr, K Guy, et al.
Transplantation|August 1, 1974
Passive enhancement of mouse skin allografts. Specificity of the antiserum for major histocompatibilityN A Staines, K Guy, D A Davies
Organic Letters|July 13, 2000
Copper-mediated cross-coupling of aryl boronic acids and alkyl thiolsP S Herradura, K A Pendola, R K Guy
Immunogenetics|January 1, 1982
Human MHC class II molecules as differentiation markersV van Heyningen, K Guy, R Newman, et al.
European Journal of Immunology|February 1, 1983
Enhanced expression of human Ia antigens by chronic lymphocytic leukemia cells following treatment with 12-O-tetradecanoylphorbol-13-acetateK Guy, V Van Heyningen, E Dewar, et al.
Pageof 9